ZimVie Inc. (ZIMV)
NASDAQ: ZIMV
· Real-Time Price · USD
18.88
0.03 (0.16%)
At close: Sep 08, 2025, 11:18 AM
ZimVie Revenue Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|
| Dental Revenue | 105.31M | 118.65M | 120.17M | 115.84M | 105.12M | 118.15M | 120.57M |
| Dental Revenue Growth | -11.24% | -1.27% | +3.74% | +10.20% | -11.03% | -2.01% | n/a |
| Segment Total Revenue | 202.87M | 224.9M | 225.09M | 228.16M | 213.27M | 233.37M | 234.68M |
| Segment Total Revenue Growth | -9.79% | -0.09% | -1.35% | +6.98% | -8.61% | -0.56% | n/a |
| Spine Revenue | 97.56M | 106.25M | 104.92M | 112.32M | 108.15M | 115.22M | 114.11M |
| Spine Revenue Growth | -8.18% | +1.27% | -6.59% | +3.85% | -6.13% | +0.97% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|
| Other Countries Revenue | 34.85M | 32.55M | 34.34M | 28.78M | 34.67M | 35.1M |
| Other Countries Revenue Growth | +7.07% | -5.23% | +19.32% | -16.99% | -1.21% | n/a |
| Spain Revenue | 13.86M | 13.62M | 12.78M | 9.09M | 12.82M | 15.35M |
| Spain Revenue Growth | +1.76% | +6.58% | +40.55% | -29.11% | -16.46% | n/a |
| United States Revenue | 67.96M | 65.83M | 64.4M | 65.35M | 69.32M | 67.75M |
| United States Revenue Growth | +3.23% | +2.22% | -1.45% | -5.72% | +2.31% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 59.57M | 58.98M | 58.56M | 57.31M | 62.38M | 60.33M | 62.91M | 117.35M | 128.48M | 127.97M | 134.46M | 129.34M | 126.05M | 134.11M | 149.3M | 135.99M | 139.99M | 129.09M | 142.3M |
| Selling, General, and Administrative Revenue Growth | +1.00% | +0.72% | +2.18% | -8.13% | +3.40% | -4.10% | -46.39% | -8.66% | +0.40% | -4.83% | +3.96% | +2.61% | -6.01% | -10.17% | +9.79% | -2.86% | +8.45% | -9.29% | n/a |
| Research and Development Revenue | 5.66M | 5.37M | 6.62M | 6.93M | 6.58M | 6.7M | 6.89M | 11.46M | 13.23M | 15.37M | 15.25M | 14.5M | 15.28M | 17.65M | 17.4M | 15.06M | 15.44M | 13.43M | 13.1M |
| Research and Development Revenue Growth | +5.42% | -18.87% | -4.42% | +5.27% | -1.82% | -2.79% | -39.84% | -13.41% | -13.93% | +0.78% | +5.19% | -5.10% | -13.43% | +1.45% | +15.51% | -2.41% | +14.95% | +2.51% | n/a |